ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 86 filers reported holding ENZO BIOCHEM INC in Q2 2014. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $213,000 | +5.4% | 41,800 | +23.6% | 0.01% | -25.0% |
| Q2 2016 | $202,000 | +146.3% | 33,820 | +86.9% | 0.02% | +220.0% |
| Q1 2016 | $82,000 | +1.2% | 18,100 | 0.0% | 0.01% | -54.5% |
| Q4 2015 | $81,000 | -37.7% | 18,100 | -38.2% | 0.01% | -15.4% |
| Q4 2014 | $130,000 | +7.4% | 29,300 | +24.7% | 0.01% | +333.3% |
| Q3 2014 | $121,000 | -1.6% | 23,500 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $123,000 | – | 23,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBERT FUND ADVISORS, INC. | 5,169,337 | $17,420,000 | 25.49% |
| Roumell Asset Management, LLC | 1,236,309 | $4,166,000 | 9.86% |
| Evermore Global Advisors, LLC | 3,587,251 | $12,089,000 | 2.28% |
| CORRADO ADVISORS, LLC | 198,544 | $669,000 | 0.60% |
| Fondren Management LP | 175,863 | $593,000 | 0.56% |
| MARATHON CAPITAL MANAGEMENT | 247,130 | $832,000 | 0.34% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $322,000 | 0.21% |
| EAM Investors, LLC | 178,939 | $603,000 | 0.15% |
| Leap Investments LP | 11,811 | $40,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 75,900 | $256,000 | 0.03% |